Palonosetron
NDC 67184-0514, Palonosetron Hydrochloride, injection, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0514
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205648
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALONOSETRON HYDROCHLORIDE.25 mg/5mL
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0514-1 | 67184051401 | 1 VIAL in 1 CARTON (67184-0514-1) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/633abdc2-a942-4eb2-a0f8-f9f4e727211e
Use it
Look up 67184-0514 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0514. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.